fundvisualizer.com

GMO International Equity IGMOUX

Performance (before sales charge)

As of 02/29/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 11/30/2023
Stock
0.13%
Non-U.S. Stock
95.98%
Bond
4.41%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
2.22%
Other
-2.74%

Due to rounding, percentages may not equal 100%.

Sectors

As of 11/30/2023

Basic materials

3.89%

Consumer cyclical

15.02%

Financial services

14.86%

Real estate

0.02%

Consumer defensive

11.90%

Health care

9.84%

Utilities

0.33%

Communication services

4.35%

Energy

7.85%

Industrials

18.47%

Technology

8.92%

Top 10 holdings

As of 11/30/2023

GMO US Treasury
6.98%
Other Liability
5.71%
TotalEnergies SE
3.16%
Novartis AG ADR
2.65%
Banco Bilbao Vizcaya Argentaria SA
2.64%
Japan Tobacco Inc
2.63%
Sanofi SA
2.43%
Compagnie de Saint-Gobain SA
2.40%
STMicroelectronics NV ADR
2.39%
Industria De Diseno Textil SA Share From Split
2.38%
Fund assets

$945.04 Million

Share class

Inst

Morningstar category

Foreign Large Value

Expense ratio

0.84%

Investment objective

Foreign Stock

Documents